The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.
about
Modelling Comparative Efficacy of Drugs with Different Survival Profiles: Ipilimumab, Vemurafenib and Dacarbazine in Advanced Melanoma.Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
P2860
The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@ast
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@en
type
label
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@ast
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@en
prefLabel
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@ast
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@en
P2093
P2860
P1433
P1476
The Predicted Impact of Ipilim ...... Metastatic Melanoma in the UK.
@en
P2093
Anthony J Hatswell
James Larkin
Paul Nathan
P2860
P304
P356
10.1371/JOURNAL.PONE.0145524
P407
P577
2015-12-23T00:00:00Z